Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda

Domaine:

healthcare

Type de record:

paper
Créateur:
LevProSimBak
Éditeur:
Pub
Hôte:
Background Tuberculosis (TB) remains the leading cause of death among people living with HIV (PLHIV). To prevent TB among PLHIV, the Ugandan national guidelines recommend Isoniazid Preventive Therapy (IPT) across differentiated service delivery (DSD) models, an effective way of delivering ART. DSD models include Community Drug Distribution Point (CDDP), Community Client-led ART Delivery (CCLAD), Facility-Based Individual Management (FBIM), Facility-Based Group (FBG), and Fast Track Drug Refill (FTDR). Little is known about the impact of delivering IPT through DSD. Methods We reviewed medical records of PLHIV who initiated IPT between June-September 2019 at TASO Soroti (TS), Katakwi Hospital (KH) and Soroti Regional Referral Hospital (SRRH). We defined IPT completion as completing a course of isoniazid within 6–9 months. We utilized a modified Poisson regression to compare IPT completion across DSD models and determine factors associated with IPT completion in each DSD model. Results Data from 2968 PLHIV were reviewed (SRRH: 50.2%, TS: 25.8%, KH: 24.0%); females: 60.7%; first-line ART: 91.7%; and Integrase Strand Transfer Inhibitor (INSTI)-based regimen: 61.9%. At IPT initiation, the median age and duration on ART were 41.5 (interquartile range [IQR]; 32.3–50.2) and 6.0 (IQR: 3.7–8.6) years, respectively. IPT completion overall was 92.8% (95%CI: 91.8–93.7%); highest in CDDP (98.1%, 95%CI: 95.0–99.3%) and lowest in FBG (85.8%, 95%CI: 79.0–90.7%). Compared to FBIM, IPT completion was significantly higher in CDDP (adjusted rate ratio [aRR] = 1.15, 95%CI: 1.09–1.22) and CCLAD (aRR = 1.09, 95% CI 1.02–1.16). In facility-based models, IPT completion differed between sites (p<0.001). IPT completion increased with age for FBIM and CCLAD and was lower among female participants in the CCLAD (aRR = 0.82, 95%CI 0.67–0.97). Conclusion IPT completion was high overall but highest in community-based models. Our findings provide evidence that supports integration of IPT within DSD models for ART delivery in Uganda and similar settings.

Visit

doi.org

Licenses

http://creativecommons.org/licenses/by/4.0/

Similaires

Differentiated HIV Service Delivery vs Conventional Care: Tuberculosis Preventive Therapy Outcomes for People Living with HIV in Sub-Saharan AfricaISONIAZID PREVENTIVE THERAPY COMPLETION AND FACTORS ASSOCIATED WITH NON-COMPLETION AMONG PATIENTS ON ANTIRETROVIRAL THERAPY AT KISENYI HEALTH CENTRE IV, KAMPALA, UGANDA.Tuberculosis treatment within differentiated service delivery models in global HIV/TB programmingDeterminants of Isoniazid Preventive Therapy Completion among People Living with HIV in Oyo and Ogun States, Southwest NigeriaDrop‐offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015–2019Strategies for isoniazid preventive therapy in HIV-positive patients who consume alcohol

Differentiated HIV Service Delivery vs Conventional Care: Tuberculosis Preventive Therapy Outcomes for People Living with HIV in Sub-Saharan Africa

Abstract Introduction Differentiated servi

ISONIAZID PREVENTIVE THERAPY COMPLETION AND FACTORS ASSOCIATED WITH NON-COMPLETION AMONG PATIENTS ON ANTIRETROVIRAL THERAPY AT KISENYI HEALTH CENTRE IV, KAMPALA, UGANDA.

This is a dataset of patients on ART intiated on Isoniazid preventive therapy (IPT) in September 201

Tuberculosis treatment within differentiated service delivery models in global HIV/TB programming

Abstract Introduction Providing more convenient and patient‐centred options for service delivery

Determinants of Isoniazid Preventive Therapy Completion among People Living with HIV in Oyo and Ogun States, Southwest Nigeria

Background: The World Health Organization (WHO) recommends the use of Isoniazid Preventive Therapy (

Drop‐offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015–2019

Abstract Introduction Isoniazid preventive therapy (IPT) can reduce the risk of tuberculosis (TB)

Strategies for isoniazid preventive therapy in HIV-positive patients who consume alcohol

BACKGROUNDWHO guidance to defer isoniazid preventive therapy (